| Primary |
| Drug Use For Unknown Indication |
37.2% |
| Product Used For Unknown Indication |
14.1% |
| Urinary Tract Infection |
12.4% |
| Pyrexia |
4.6% |
| Cystitis |
3.4% |
| Hypertension |
3.4% |
| Unevaluable Event |
3.4% |
| Pneumonia |
2.9% |
| Prostatitis |
2.7% |
| Diabetic Foot |
2.1% |
| Atrial Fibrillation |
1.9% |
| Infection |
1.7% |
| Antibiotic Therapy |
1.5% |
| Kidney Infection |
1.5% |
| Pain |
1.5% |
| Bone Marrow Conditioning Regimen |
1.3% |
| Diarrhoea |
1.3% |
| Osteomyelitis |
1.3% |
| Bronchitis |
1.1% |
| Device Related Infection |
1.1% |
|
| Vomiting |
14.0% |
| Tendon Rupture |
10.8% |
| Tendon Pain |
8.6% |
| Tendonitis |
6.5% |
| Urticaria |
5.4% |
| Vasculitis |
5.4% |
| Ventricular Tachycardia |
5.4% |
| Pruritus |
4.3% |
| Rash |
4.3% |
| Clostridium Difficile Colitis |
3.2% |
| Neutropenia |
3.2% |
| Oedema Peripheral |
3.2% |
| Orthostatic Hypotension |
3.2% |
| Pain |
3.2% |
| Paraesthesia |
3.2% |
| Purpura |
3.2% |
| Pyrexia |
3.2% |
| Renal Failure Acute |
3.2% |
| Serotonin Syndrome |
3.2% |
| Thrombosis |
3.2% |
|
| Secondary |
| Product Used For Unknown Indication |
31.1% |
| Drug Use For Unknown Indication |
14.0% |
| Urinary Tract Infection |
7.3% |
| Hypertension |
6.7% |
| Pain |
5.5% |
| Antibiotic Therapy |
3.9% |
| Febrile Bone Marrow Aplasia |
3.8% |
| Pneumonia |
3.5% |
| Interstitial Lung Disease |
3.1% |
| Osteomyelitis |
3.1% |
| Prophylaxis |
2.7% |
| Diabetic Foot |
2.2% |
| Diverticulitis |
2.1% |
| Infection |
2.1% |
| Sepsis |
2.0% |
| Ascites |
1.5% |
| Crohn's Disease |
1.4% |
| Epstein-barr Virus Associated Lymphoproliferative Disorder |
1.4% |
| Cystitis |
1.2% |
| Febrile Infection |
1.2% |
|
| Drug Rash With Eosinophilia And Systemic Symptoms |
9.8% |
| Renal Failure Acute |
9.8% |
| Rash Maculo-papular |
8.0% |
| Pseudomembranous Colitis |
6.3% |
| Toxic Epidermal Necrolysis |
6.3% |
| Drug Ineffective |
5.4% |
| Peritoneal Haemorrhage |
5.4% |
| Tendon Disorder |
5.4% |
| Retching |
4.5% |
| Rhabdomyolysis |
4.5% |
| Skin Exfoliation |
4.5% |
| Anaphylactic Shock |
3.6% |
| Hepatitis |
3.6% |
| Hepatocellular Damage |
3.6% |
| Neutropenia |
3.6% |
| Rash |
3.6% |
| Thrombocytopenia |
3.6% |
| Vitamin K Deficiency |
3.6% |
| Cardiac Failure |
2.7% |
| Cytolytic Hepatitis |
2.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
19.6% |
| Drug Use For Unknown Indication |
16.1% |
| Prophylaxis |
12.2% |
| Infection Prophylaxis |
4.9% |
| Hypertension |
4.6% |
| Crohn's Disease |
4.2% |
| Acute Myeloid Leukaemia |
4.1% |
| Urinary Tract Infection |
3.5% |
| Premedication |
3.4% |
| Hiv Infection |
3.2% |
| Multiple Myeloma |
3.1% |
| Bone Marrow Conditioning Regimen |
3.1% |
| Depression |
3.0% |
| Antifungal Prophylaxis |
2.7% |
| Pain |
2.5% |
| Nausea |
2.4% |
| Prophylaxis Against Graft Versus Host Disease |
2.0% |
| Acute Lymphocytic Leukaemia |
1.9% |
| Osteoporosis |
1.9% |
| Constipation |
1.8% |
|
| Vomiting |
11.3% |
| Weight Decreased |
10.2% |
| Pyrexia |
9.4% |
| Urinary Tract Infection |
7.8% |
| White Blood Cell Count Decreased |
7.8% |
| Sepsis |
5.9% |
| Pancreatitis Acute |
5.5% |
| Thrombocytopenia |
5.1% |
| Weight Increased |
4.3% |
| Respiratory Failure |
3.5% |
| Visual Impairment |
3.5% |
| Arrhythmia |
3.1% |
| Febrile Neutropenia |
3.1% |
| Neutropenia |
3.1% |
| Wound Drainage |
3.1% |
| Candidiasis |
2.7% |
| Pneumonia |
2.7% |
| Sinusitis |
2.7% |
| Wheelchair User |
2.7% |
| Deep Vein Thrombosis |
2.3% |
|
| Interacting |
| Product Used For Unknown Indication |
31.7% |
| Pyrexia |
11.4% |
| Drug Use For Unknown Indication |
9.8% |
| Lung Disorder |
5.7% |
| Bone Marrow Conditioning Regimen |
4.9% |
| Diverticulitis |
4.9% |
| Dyspepsia |
3.3% |
| Sedation |
3.3% |
| Urinary Tract Infection |
3.3% |
| Analgesic Therapy |
2.4% |
| Hypertension |
2.4% |
| Infection |
2.4% |
| Mental Disorder |
2.4% |
| Nasopharyngitis |
2.4% |
| Anaesthesia |
1.6% |
| Atrial Fibrillation |
1.6% |
| Device Related Infection |
1.6% |
| Epstein-barr Virus Infection |
1.6% |
| Hyperlipidaemia |
1.6% |
| Pneumonia |
1.6% |
|
| Graft Versus Host Disease |
15.8% |
| International Normalised Ratio Increased |
10.5% |
| Mucocutaneous Candidiasis |
10.5% |
| Abdominal Wall Haematoma |
5.3% |
| Disorientation |
5.3% |
| Drug Interaction |
5.3% |
| Hypoglycaemia |
5.3% |
| Hypotension |
5.3% |
| Myalgia |
5.3% |
| Overdose |
5.3% |
| Peritonitis |
5.3% |
| Pneumonia Aspiration |
5.3% |
| Rectal Haemorrhage |
5.3% |
| Tendon Pain |
5.3% |
| Ventricular Tachycardia |
5.3% |
|
